Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:    
Net loss $ (24,449) $ (17,464)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 856 691
Stock-based compensation 2,112 1,387
Non-cash lease expense 672
Non-cash interest expense 494 498
Non-cash advertising expense 200 400
Non-cash portion of loss on debt extinguishment 1,087 161
Forgiveness of PPP loan (2,180)
Loss on disposal of property and equipment 5 16
Provision for bad debt 38 (54)
Deferred rent 338
Changes in operating assets and liabilities:    
Accounts receivable 786 (4,431)
Prepaid expenses and other current assets 153 (899)
Deposits and other assets (170) 53
Accounts payable 88 1,015
Accrued expenses and other liabilities 1,175 1,499
Deferred revenues 1,016 799
Operating ease Liability (758)
Customer deposits (78) (421)
Net cash used in operating activities (16,773) (18,592)
Cash flows from investing activities:    
Purchase of property and equipment (1,408) (611)
Net cash used in investing activities (1,408) (611)
Cash flows from financing activities:    
Payment to unaccredited investors of Augmedix Operating Corporation (22)
Proceeds from sale of common stock 40,000
Proceeds from exercise of common stock warrants 4
Payment of offering costs in relation to common stock issuance (4,109)
Proceeds from exercise of stock options 30 152
Proceeds from loan payable 15,000 15,000
Repayment of note payable (12,966)
Repayment of Eastward Loan (16,125)
Payment of financing costs (142) (232)
Net cash provided by financing activities (1,237) 37,827
Effect of exchange rate changes on cash and restricted cash (181) (10)
Net increase (decrease) in cash and restricted cash (19,599) 18,614
Cash and restricted cash at beginning of year 41,587 22,973
Cash and restricted cash at end of year 21,988 41,587
Supplemental disclosure of cash flow information:    
Cash paid during the year for interest 1,242 1,613
Cash paid during the year for taxes 34 44
Supplemental schedule of non-cash investing and financing activities:    
Fair value of warrants issued in connection with loan 72 395
Fair value of common stock issued to service provider 600
Property, plant, and equipment in accounts payable $ 137 $ 91